Last mentioned: Mar 25, 2026
Official Reporting
MHRA and GOV.UK release data confirming the surge in neurotech and AI testing activity.
Record Achievement
Total CINs for the year reach 137, a new historical high for the agency.
IDAP Expansion
The MHRA expands the Innovative Devices Access Pathway to include more AI-driven startups.
Baseline Growth
UK concludes 2024 with 104 clinical investigation notifications.
Researchers have developed an ultra-miniature neural implant smaller than a grain of salt capable of wireless brain activity transmission for over a year. Powered by laser light and utilizing infrared signals, the device offers a non-invasive alternative to traditional wired brain-computer interfaces.
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) reported a record 137 clinical investigation notifications in 2025, a 32% increase over the previous year. This surge is driven by a strategic regulatory pivot toward AI-driven diagnostics and brain-computer interfaces, signaling the UK's intent to lead in high-risk medical innovation.